Abstract
Plasma salicylate concentration was monitored in 42 children on long-term salicylate therapy for rheumatoid arthritis. A given dose of salicylate per kg resulted in large variations in plasma levels, both between individuals and for a single individual at different times. The factors responsible for such variations were studied; in 6 cases urinary metabolites of salicylate were analysed. The relation between salicylate dosage and plasma half-life accounts for the fact that small changes in dosage can result in large changes in plasma concentration. The addition of corticosteroid or ACTH therapy results in lower plasma levels of salicylate, and necessitates higher dosage of salicylate. After the introduction of routine monitoring of plasma salicylate, the incidence of toxic symptoms fell sharply.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Buchanan N., Rabinowitz L. Infantile salicylism--a reappraisal. J Pediatr. 1974 Mar;84(3):391–395. doi: 10.1016/s0022-3476(74)80722-5. [DOI] [PubMed] [Google Scholar]
- Calabro J. J. Management of juvenile rheumatoid arthritis. J Pediatr. 1970 Sep;77(3):355–365. doi: 10.1016/s0022-3476(70)80001-4. [DOI] [PubMed] [Google Scholar]
- DONE A. K. Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion. Pediatrics. 1960 Nov;26:800–807. [PubMed] [Google Scholar]
- Gibson T., Zaphiropoulos G., Grove J., Widdop B., Berry D. Kinetics of salicylate metabolism. Br J Clin Pharmacol. 1975 Jun;2(3):233–238. doi: 10.1111/j.1365-2125.1975.tb01581.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klinenberg J. R., Miller F. Effect of corticosteroids on blood salicylate concentration. JAMA. 1965 Nov 8;194(6):601–604. [PubMed] [Google Scholar]
- Levy G., Tsuchiya T., Amsel L. P. Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):258–268. doi: 10.1002/cpt1972132258. [DOI] [PubMed] [Google Scholar]
- Levy G., Tsuchiya T. Salicylate accumulation kinetics in man. N Engl J Med. 1972 Aug 31;287(9):430–432. doi: 10.1056/NEJM197208312870903. [DOI] [PubMed] [Google Scholar]
- Levy G., Yaffe S. J. Relationship between dose and apparent volume of distribution of salicylate in children. Pediatrics. 1974 Dec;54(6):713–717. [PubMed] [Google Scholar]
- MACPHERSON C. R., MILNE M. D., EVANS B. M. The excretion of salicylate. Br J Pharmacol Chemother. 1955 Dec;10(4):484–489. doi: 10.1111/j.1476-5381.1955.tb00109.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mäkelä A. L., Tryänä T., Haapasaari J. Dosage of salicylates for children with juvenile rheumatoid arthritis. A preliminary report. Scand J Rheumatol. 1975;4(4):250–252. doi: 10.3109/03009747509165266. [DOI] [PubMed] [Google Scholar]
- Paulus H. E., Siegel M., Mongan E., Okun R., Calabro J. J. Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. Arthritis Rheum. 1971 Jul-Aug;14(4):527–532. doi: 10.1002/art.1780140412. [DOI] [PubMed] [Google Scholar]
- Pierce A. W., Jr Salicylate poisoning. Pediatrics. 1974 Sep;54(3):342–347. [PubMed] [Google Scholar]
- SCHACHTER D., MANIS J. G. Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. J Clin Invest. 1958 Jun;37(6):800–807. doi: 10.1172/JCI103667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TSCHETTER P. N. SALICYLISM. Am J Dis Child. 1963 Sep;106:334–346. doi: 10.1001/archpedi.1963.02080050336016. [DOI] [PubMed] [Google Scholar]
